Health Care: Drugs

Pacira Pharmaceuticals Inc (PCRX: NASDAQ)

$45.15 n/a | n/a%
05/26/17 - 04:00 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 276.37M 249.00M 197.67M 85.55M
Cost of Sales 92.62M 55.78M 62.78M 44.61M
Gross Operating Profit 183.75M 193.22M 134.89M 40.94M
Selling, General, and Administrative Expenses 152.61M 139.04M 106.66M 62.51M
Research & Development 45.68M 28.66M 18.73M 21.56M
Operating Income before D & A (EBITDA) -14.54M 25.51M 9.50M -43.12M
Depreciation & Amortization 17.49M 16.06M 14.66M 10.16M
Interest Income 1.32M 678.00K 382.00K 259.00K
Other Income - Net -82.00K -288.00K -482.00K -8.62M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -30.78M 9.85M -5.26M -61.65M
Interest Expense 7.06M 7.72M 8.28M 2.70M
Pre-Tax Income -37.84M 2.12M -13.54M -64.35M
Income Taxes 105.00K 264.00K 173.00K -442.00K
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -37.95M 1.86M -13.72M -63.91M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -37.95M 1.86M -13.72M -63.91M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -37.95M 1.86M -13.72M -63.91M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-37.95M 1.86M -13.72M -63.91M
Preferred Dividends
Net Income Available To Common -37.95M 1.86M -13.72M -63.91M
Basic EPS from Continuing Ops. -1.02 0.05 -0.39 -1.93
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -1.02 0.05 -0.39 -1.93
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -1.02 0.05 -0.39 -1.93
Basic Normalized Net Income/Share -1.02 0.05 -0.39 -1.93
EPS fr Continuing Ops. -1.02 0.04 -0.39 -1.93
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -1.02 0.04 -0.39 -1.93
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -1.02 0.04 -0.39 -1.93
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-1.02 0.04 -0.39 -1.93
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with PCRX

Latest PCRX Headlines from TheStreet

More Financial News for PCRX

Press Releases for PCRX

See All Press Releases

Partner Headlines for PCRX

brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter